Search clinical trials for: Sacituzumab Govitecan-hziy
Total 111 results
-
Georgetown UniversityGilead SciencesRecruitingThymic Carcinoma | ThymomaUnited States
-
Gilead SciencesRecruitingLiver Failure | Advanced or Metastatic Solid TumorFrance, United States
-
Veru Inc.WithdrawnMetastatic Triple Negative Breast Cancer
-
Gilead SciencesActive, not recruitingMetastatic Solid TumorUnited States, Spain, France, Hong Kong, Australia, Belgium, Taiwan, Canada
-
Gilead SciencesParexel; IQVIA RDS (Shanghai) Co., Ltd.; Medidata Solutions; Q Squared Solutions...Active, not recruitingMetastatic Triple-negative Breast CancerChina
-
Gilead SciencesRecruiting
-
Gilead SciencesRecruitingStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors (ASCENT-J02)Advanced Solid Tumor | Metastatic Urothelial Cancer | Metastatic Triple-Negative Breast Cancer | HR+/HER2- Metastatic Breast CancerJapan
-
Gilead SciencesCompletedCervical Cancer | Urinary Bladder Neoplasms | Small Cell Lung Cancer | Hepatocellular Carcinoma | Pancreatic Cancer | Esophageal Cancer | Ovarian Epithelial Cancer | Glioblastoma Multiforme | Gastric Adenocarcinoma | Triple Negative Breast Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Renal Cell Cancer and other conditionsUnited States
-
G1 Therapeutics, Inc.Active, not recruitingTriple Negative Breast CancerUnited States
-
Gilead SciencesEnrolling by invitationMetastatic Solid TumorFrance, United States, Belgium
-
Gilead SciencesActive, not recruitingNon-Small Cell Lung CancerUnited States, Belgium, Spain, United Kingdom, Australia, Japan, Italy, France, Israel, Netherlands, Puerto Rico, Portugal, Greece, Brazil, Poland, Canada, Austria, Germany, Mexico, Turkey
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Gilead SciencesRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Metastatic Malignant Neoplasm in the Brain | Metastatic HER2 Negative Breast CarcinomaUnited States
-
Gilead SciencesRecruiting
-
Icahn School of Medicine at Mount SinaiNot yet recruitingOvarian Cancer | Malignant Neoplasm of UterusUnited States
-
Gilead SciencesApproved for marketingMetastatic Triple-Negative Breast Carcinoma
-
ImmunityBio, Inc.TerminatedAdvanced Triple Negative Breast CancerUnited States
-
Fudan UniversityRecruiting
-
The University of Texas Health Science Center at...Recruiting
-
M.D. Anderson Cancer CenterGilead SciencesRecruitingSalivary Gland Cancers | GlandUnited States
-
SOLTI Breast Cancer Research GroupNot yet recruitingBreast Cancer Stage IVSpain
-
The University of Texas Health Science Center at...Gilead SciencesActive, not recruiting
-
Gilead SciencesCompletedMetastatic Breast CancerUnited States, Spain, United Kingdom, Italy, Canada, France, Germany, Belgium, Netherlands
-
University Hospital HeidelbergNot yet recruitingMetastatic Colorectal CancerGermany
-
National Cancer Institute (NCI)RecruitingAdvanced Solid Tumors | SCLC | HRD CancerUnited States
-
Yale UniversityGilead SciencesRecruitingEndometrial CarcinomaUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Gilead SciencesRecruiting
-
IRCCS San RaffaeleHigh ResearchRecruiting
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)SuspendedMetastatic Triple-Negative Breast Carcinoma | Metastatic HER2-Negative Breast CarcinomaUnited States
-
Gilead SciencesAlliance Foundation Trials, LLC.Recruiting
-
Gilead SciencesMerck Sharp & Dohme LLCActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Italy, France, Australia, Hong Kong, Korea, Republic of, Malaysia, Taiwan, Germany, United Kingdom, Canada
-
Dragonfly TherapeuticsRecruitingSolid Tumor, AdultUnited States, Denmark, Netherlands, Belgium, France
-
University of WashingtonGilead SciencesRecruitingStage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8United States
-
Gilead SciencesRecruitingAdvanced Solid TumorsUnited States
-
Gilead SciencesMerck KGaA, Darmstadt, GermanyRecruitingMetastatic Urothelial CancerItaly, United States, Korea, Republic of, Spain, Greece, France, Germany, United Kingdom, Turkey
-
Dana-Farber Cancer InstituteGilead SciencesActive, not recruitingBladder Cancer | Urothelial Cancer | Metastatic Urothelial Carcinoma | Metastatic Urothelial Carcinoma of the Renal Pelvis and UreterUnited States
-
Gilead SciencesEverest MedicinesActive, not recruitingLocally Advanced or Metastatic Unresectable Urothelial CancerUnited States, Belgium, France, Spain, United Kingdom, Korea, Republic of, Czechia, Germany, Israel, China, Italy, Australia, Hong Kong, Taiwan, Portugal, Singapore, Croatia, Greece, Turkey, Sweden, Switzerland, Canada, Austria, Bulgaria and more
-
Gilead SciencesActive, not recruitingTriple-Negative Breast CancerUnited States, United Kingdom, Australia, Hong Kong, Korea, Republic of, Taiwan
-
Alkermes, Inc.CompletedBinge Eating DisorderUnited States
-
Gilead SciencesRecruitingStage IV Breast Cancer | Locally Advanced or Unresectable Metastatic Breast CancerTaiwan, Korea, Republic of, Greece, Spain, United States, Israel, France, Japan, Belgium, Poland, China, Singapore, Australia, Hungary, Czechia, Italy, South Africa, Hong Kong, Chile, Brazil, Argentina, Austria, Canada, Germany, Portugal, United Kingdom
-
University of Kansas Medical CenterGilead Sciences; Novartis PharmaceuticalsRecruitingBreast CancerUnited States
-
Gilead SciencesRecruitingTriple Negative Breast Cancer | PD-L1 NegativeUnited States, Hong Kong, Belgium, Australia, Austria, Israel, Spain, Korea, Republic of, Taiwan, China, Japan, Netherlands, Brazil, Canada, Turkey, France, Germany, Malaysia, United Kingdom, Singapore, Hungary, Mexico, Italy, Switzer... and more
-
Adrienne G. WaksGilead SciencesRecruitingBreast Cancer Female | Breast Cancer Metastatic | Her 2 Positive Breast CancerUnited States
-
Ana C Garrido-Castro, MDMerck Sharp & Dohme LLC; Gilead SciencesActive, not recruitingMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | HR-Positive Breast CancerUnited States
-
Massachusetts General HospitalGilead SciencesRecruitingTriple Negative Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast CancerUnited States
-
Hope Rugo, MDJohns Hopkins University; Pfizer; Gilead Sciences; Hoosier Cancer Research Network and other collaboratorsRecruitingStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Unresectable Breast Carcinoma | Stage IIIC Breast Cancer | Triple-Negative Breast Carcinoma | Stage III Breast CancerUnited States
-
Gilead SciencesParexel; Iqvia Pty Ltd; Medidata SolutionsActive, not recruitingMetastatic Breast CancerKorea, Republic of, Taiwan, China
-
Massachusetts General HospitalPfizerRecruiting
-
Chinese University of Hong KongRecruiting
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; Gilead SciencesRecruitingBreast Cancer | Triple Negative Breast Cancer | PD-L1 NegativeUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar TherapeuticsRecruitingLocally Advanced or Metastatic Urothelial CarcinomaKorea, Republic of, United States, Taiwan, Australia, United Kingdom, France, Greece, Italy, Belgium, Spain, Canada, Denmark, Germany